Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase IV, open-label, multi-centre study to assess the long-term persistence of hepatitis A and B antibodies in healthy adult subjects, primed 16 to 20 years earlier with GSK Biologicals’ combined hepatitis A and B vaccine, Twinrix® (SB208127) in study HAB-084 (208127/084) https://kusajili.com:443/Trial/PbASazAOzEi3hI9z_bcNhg%24a-phase-iv-open-label-multi-centre-study-to-assess-the-long-term-persistence-of-hepatitis-a-and-b-antibodies-in-healthy-adult-s
I have read and accept the terms of use of the site and the Privacy Policy
Send your message